GO:0000900 mRNA regulatory element binding translation repressor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000900 describes a molecular function where a protein binds directly and non-covalently to a regulatory element in an mRNA and antagonizes ribosome-mediated translation into polypeptide.
• The term is defined by two inseparable activities: selective nucleic acid binding and translational repression, as demonstrated for iron-regulatory proteins IRP1 and IRP2 [3,8].
• Classic examples include iron-responsive element (IRE)-binding proteins that repress ferritin and other mRNAs in response to iron status [3,8].
• Bacterial Csr (Rsm) systems use RNA-binding proteins to repress translation of target mRNAs, illustrating conservation of this function [1,6].
• The activity is often autoregulatory, as seen for poly(A)-binding protein mRNA, which forms a heteromeric ribonucleoprotein complex to control its own translation.
• Dysregulation of this activity is linked to cancer, neurodegeneration, and iron metabolism disorders, making it a target for CRISPR-based functional studies [3,4,5].
Description
GO:0000900, mRNA regulatory element binding translation repressor activity, is a molecular function that antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct, selective, and non-covalent binding to nucleic acid. This activity is essential for post-transcriptional gene regulation, allowing cells to rapidly adjust protein synthesis without altering mRNA levels. The function is best exemplified by iron-regulatory proteins (IRPs), which bind iron-responsive elements (IREs) in target mRNAs and repress translation when iron is scarce [3,8]. In bacteria, Csr (Rsm) RNA-binding proteins repress translation of specific mRNAs to control virulence and metabolism [1,6]. The activity is also autoregulatory, as seen for poly(A)-binding protein (PABP) mRNA, where a translational control element forms a heteromeric ribonucleoprotein complex to repress its own translation. Understanding this function is critical for researchers studying gene expression, iron homeostasis, and host-pathogen interactions, and it provides a paradigm for RNA-targeted therapeutics.
mRNA regulatory element binding translation repressor activity At A Glance
| GO ID | GO:0000900 |
|---|---|
| GO term | mRNA regulatory element binding translation repressor activity |
| Ontology | molecular_function |
| Synonym | translation repressor activity, mRNA regulatory element binding; translation repressor activity, nucleic acid binding |
| Definition | Antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct binding (through a selective and non-covalent interaction) to nucleic acid. |
| Major function | Repression of translation through sequence-specific mRNA binding |
| Example proteins | IRP1, IRP2, CsrA, PABP |
| Cellular context | Cytoplasm, ribonucleoprotein complexes |
What Is GO:0000900?
In my own words, GO:0000900 refers to the function of a protein that binds to a specific regulatory sequence or structure within an mRNA molecule and, through that binding, prevents the mRNA from being translated into protein by the ribosome. The binding is selective and non-covalent, and the repression is achieved by blocking ribosome recruitment, scanning, or elongation. This activity is distinct from general translation inhibitors because it requires direct nucleic acid binding and targets specific mRNAs.
Why Is mRNA regulatory element binding translation repressor activity Important in Cell Biology?
This activity is a cornerstone of post-transcriptional gene regulation, enabling cells to rapidly reprogram protein synthesis in response to stress, nutrients, and infection. It is critical for iron homeostasis, bacterial virulence, and developmental transitions, and its dysregulation contributes to cancer and neurodegeneration [3,4,5,6].
• Controls iron metabolism by repressing ferritin and other mRNAs when iron is scarce [3,8].
• Regulates bacterial virulence and carbon metabolism through Csr/Rsm systems [1,6].
• Mediates autoregulation of poly(A)-binding protein, affecting mRNA stability and translation.
• Plays a role in cancer, as p53 regulates C/EBPβ expression and IRP activity is altered in tumors.
• Linked to neurodegeneration through α-synuclein and iron-responsive mRNA regulation.
• Provides a mechanism for rapid, reversible translational control without mRNA degradation.
• Serves as a model for RNA-targeted drug discovery and CRISPR screens [1,3].
• Enables precise dissection of gene function using knockout and point-mutation models.
What Happens During mRNA regulatory element binding translation repressor activity?
Recognition of the mRNA regulatory element
In simple terms: The repressor protein finds and binds to a specific shape or sequence in the mRNA.
The first step is the selective, non-covalent binding of the repressor protein to a regulatory element in the mRNA, such as an iron-responsive element (IRE) or a CsrA-binding site [3,6]. This binding is often mediated by RNA-binding domains that recognize stem-loop structures or single-stranded motifs. For IRP1 and IRP2, the IRE is a conserved stem-loop in the 5' or 3' untranslated region of target mRNAs [3,8].
Formation of a repressive ribonucleoprotein complex
In simple terms: The protein and mRNA together form a complex that blocks translation.
Upon binding, the repressor protein may recruit additional factors to form a heteromeric ribonucleoprotein complex, as seen for the poly(A)-binding protein mRNA autoregulatory element. This complex physically obstructs the ribosome or its accessory factors, preventing translation initiation or elongation. In the Csr system, CsrA binding to mRNA inhibits translation by blocking ribosome binding [1,6].
Inhibition of translation initiation or elongation
In simple terms: The complex stops the ribosome from making protein.
The repressive complex antagonizes ribosome-mediated translation. For IRE-bound IRPs, repression occurs at the level of translation initiation, likely by preventing recruitment of the 43S preinitiation complex. In other cases, the repressor may stall elongation. The exact mechanism depends on the mRNA and the repressor, but the outcome is reduced polypeptide synthesis [3,8].
Regulation by cellular signals
In simple terms: The repressor's activity is switched on or off by signals like iron levels.
The activity is tightly regulated by cellular cues. For example, IRP1 switches between a translational repressor and a cytosolic aconitase depending on iron availability, a process known as the iron switch. In bacteria, CsrA activity is modulated by small RNAs and the RNA-binding protein CsrB, which sequester CsrA [1,6]. This regulation ensures that translation repression is reversible and context-dependent.
Key Genes Involved in GO:0000900 mRNA regulatory element binding translation repressor activity
The following genes encode proteins that directly mediate mRNA regulatory element binding translation repressor activity or are key targets of this regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IRP1 (ACO1) | Binds IREs; translational repressor and aconitase | Iron homeostasis, cancer metabolism [3,8] |
| IRP2 (IREB2) | Binds IREs; translational repressor | Iron metabolism, neurodegeneration |
| CsrA (RsmA) | RNA-binding protein; represses translation of target mRNAs | Bacterial virulence, biofilm formation [1,6] |
| PABP (PABPC1) | Binds poly(A) tail; autoregulates its own mRNA | mRNA stability, translation |
| Zap1 | Transcriptional activator; regulates RTC4 mRNA translation via alternative leaders | Zinc homeostasis |
| C/EBPβ | Transcription factor; regulated by p53 at translational level | Cancer, inflammation |
| α-Synuclein (SNCA) | Iron-responsive mRNA binding; regulates translation | Parkinson's disease |
| eIF4F complex | Translation initiation factor; target of repression | Cancer, translation control |
| RTC4 | mRNA target of Zap1-mediated repression | Zinc homeostasis |
| CsrB | Small RNA; sequesters CsrA | Bacterial regulation |
| CsrC | Small RNA; sequesters CsrA | Bacterial regulation |
| RsmZ | Small RNA; sequesters RsmA | Bacterial regulation |
| RsmY | Small RNA; sequesters RsmA | Bacterial regulation |
| Ferritin (FTL/FTH1) | mRNA target of IRP repression | Iron storage |
| Transferrin receptor (TFRC) | mRNA target of IRP regulation | Iron uptake |
| ACO1 | Gene encoding IRP1 | Iron-sulfur cluster metabolism |
| IREB2 | Gene encoding IRP2 | Iron metabolism |
How Is mRNA regulatory element binding translation repressor activity Regulated?
The activity of mRNA regulatory element binding translation repressors is controlled at multiple levels. IRP1 activity is regulated by an iron-sulfur cluster switch: when iron is abundant, IRP1 binds a 4Fe-4S cluster and functions as aconitase; when iron is scarce, it loses the cluster and binds IREs to repress translation. IRP2 is regulated by iron-dependent degradation via the proteasome. In bacteria, CsrA activity is modulated by small non-coding RNAs (CsrB, CsrC) that sequester the protein, and by the BarA/UvrY two-component system [1,6]. Additionally, the Zap1 transcriptional activator negatively regulates translation of RTC4 mRNA through alternative 5' transcript leaders, linking zinc status to translational control. These regulatory circuits ensure that translational repression is dynamic and responsive to cellular needs.
mRNA regulatory element binding translation repressor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IRP1 (ACO1) | Iron metabolism disorders, cancer | Knockout and point-mutation cell lines |
| IRP2 (IREB2) | Neurodegeneration, iron overload | Knock-in of mutant IREB2 |
| CsrA | Bacterial virulence | Bacterial knockout and overexpression |
| SNCA | Parkinson's disease | Overexpression and knockout neuronal cells |
| C/EBPβ | Cancer, inflammation | CRISPR knockout in cancer cell lines |
Cancer
Dysregulated translational repression contributes to cancer. p53 regulates CCAAT/Enhancer binding protein β (C/EBPβ) gene expression, and IRP activity is altered in cancer cells to support iron demand for proliferation. Targeting IRP-mediated repression may offer therapeutic opportunities.
Neurodegeneration
Iron dyshomeostasis and α-synuclein aggregation are hallmarks of Parkinson's disease. α-Synuclein binds iron-responsive mRNAs and modulates eIF4F complex activity, linking translational repression to neurodegeneration. IRP2 dysfunction is also implicated in neurodegenerative disorders.
Bacterial infections
Csr/Rsm systems are critical for bacterial virulence. CsrA represses translation of genes involved in motility, biofilm formation, and virulence, making it a target for anti-infective strategies [1,6].
Iron metabolism disorders
Mutations affecting IRP-IRE interactions cause hereditary hyperferritinemia-cataract syndrome and iron-refractory iron deficiency anemia, highlighting the importance of this translational repression in human health [3,8].
From mRNA regulatory element binding translation repressor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of IRP1 affect ferritin translation? | IRP1 knockout cell line |
| Does a point mutation in the IRE abolish repression? | Point-mutation knock-in of IRE sequence |
| Can we tag IRP2 to track its binding? | Tagged knock-in of IRP2 |
| Does overexpression of CsrA repress virulence genes? | CsrA overexpression in bacteria |
| Which mRNAs are bound by IRP1? | RIP-seq or CLIP-seq in wild-type and knockout |
| Can we screen for regulators of translation repression? | CRISPR library screening with reporter |
How to Study the mRNA regulatory element binding translation repressor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Global translation profiling |
| RNA-seq | mRNA abundance | Transcriptome changes |
| RIP-seq/CLIP-seq | Protein-RNA interactions | Target identification |
| Polysome profiling | Distribution of mRNAs in polysomes | Translational repression |
| Luciferase reporter | Reporter activity | Element validation |
| Western blot | Protein levels | Validation of repression |
| CRISPR screen | Gene essentiality or reporter repression | Functional genomics |
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy on mRNAs, providing a snapshot of translation efficiency. It can identify mRNAs whose translation is repressed by IRP or CsrA [3,6].
RNA immunoprecipitation (RIP) and CLIP
RIP and CLIP enable identification of direct mRNA targets bound by the repressor protein, confirming the nucleic acid binding step.
Polysome profiling
Polysome profiling separates actively translated mRNAs from untranslated ones, allowing assessment of translational repression in response to iron or other signals.
Reporter assays
Luciferase reporters fused to regulatory elements (e.g., IRE) are used to quantify repression activity and test mutations.
How CRISPR Can Be Used to Study GO:0000900 mRNA regulatory element binding translation repressor activity
Knockout
CRISPR knockout of IRP1, IRP2, or CsrA eliminates the repressor, leading to derepression of target mRNAs. This is used to study iron metabolism and bacterial virulence [3,6].
Point Mutation
Point mutations in the RNA-binding domain or in the mRNA regulatory element can abolish binding and repression. These models help dissect the specificity of the interaction.
Knock-in
Knock-in of tagged versions (e.g., FLAG, GFP) of IRP1 or CsrA allows tracking of protein localization and interaction with mRNA in live cells.
Overexpression
Overexpression of the repressor protein enhances repression, useful for gain-of-function studies and for testing resistance to repression [1,5].
How EDITGENE Supports mRNA regulatory element binding translation repressor activity Research
Researchers studying mRNA regulatory element binding translation repressor activity-related genes often need to determine whether a candidate gene is causally involved in translational control, iron homeostasis, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for mRNA regulatory element binding translation repressor activity research.
Frequently Asked Questions About mRNA regulatory element binding translation repressor activity
What is GO:0000900?
GO:0000900 is a molecular function term describing proteins that bind to mRNA regulatory elements and repress translation.
What genes are involved in mRNA regulatory element binding translation repressor activity?
Key genes include IRP1 (ACO1), IRP2 (IREB2), CsrA, and PABP [3,6,7,8].
How does iron regulate translation repression?
Iron controls IRP1's switch between aconitase and RNA-binding forms, affecting ferritin translation.
What diseases are linked to this activity?
Cancer, neurodegeneration, iron disorders, and bacterial infections [1,3,4,5,6].
What methods study translational repression?
Ribo-seq, polysome profiling, RIP-seq, and reporter assays [3,7,8].
Can CRISPR be used to study this function?
Yes, knockout, point mutation, knock-in, and overexpression models are available [1,3,8].
What is the role of CsrA in bacteria?
CsrA represses translation of virulence and motility genes [1,6].
How is PABP mRNA autoregulated?
PABP mRNA forms a heteromeric ribonucleoprotein complex that represses its own translation.
What is the iron switch?
IRP1 switches between aconitase and translational repressor depending on iron levels.
How can I model this activity in the lab?
Use CRISPR knockout or reporter assays in cell lines [3,8].
Conclusion
GO:0000900 mRNA regulatory element binding translation repressor activity is a fundamental post-transcriptional control mechanism with broad implications for iron metabolism, bacterial pathogenesis, and human disease. Understanding its molecular details and regulatory networks provides insights into gene expression and offers targets for therapeutic intervention. CRISPR-based models are indispensable for dissecting this activity and translating findings into clinical applications.
References
- 1. Seyll E et al.. 2013. The ribonucleoprotein Csr network.. Int J Mol Sci 14(11):22117-31 PMID: 24217225
- 2. Bird AJ et al.. 2017. The Zap1 transcriptional activator negatively regulates translation of the RTC4 mRNA through the use of alternative 5' transcript leaders.. Mol Microbiol 106(5):673-677 PMID: 28971534
- 3. Gray NK et al.. 1993. Recombinant iron-regulatory factor functions as an iron-responsive-element-binding protein, a translational repressor and an aconitase. A functional assay for translational repression and direct demonstration of the iron switch.. Eur J Biochem 218(2):657-67 PMID: 8269957
- 4. Hu B et al.. 2023. P53 regulates CCAAT/Enhancer binding protein β gene expression.. Gene 884:147675 PMID: 37541559
- 5. Khan MA. 2025. Fe(2+)-Sensing α-Synuclein Iron-Responsive Messenger RNA/eIF4F Complex Binding and Regulating mRNA Translation Activation and Repression.. Int J Mol Sci 26(19) PMID: 41096590
- 6. Vakulskas CA et al.. 2015. Regulation of bacterial virulence by Csr (Rsm) systems.. Microbiol Mol Biol Rev 79(2):193-224 PMID: 25833324
- 7. Patel GP et al.. 2005. The autoregulatory translational control element of poly(A)-binding protein mRNA forms a heteromeric ribonucleoprotein complex.. Nucleic Acids Res 33(22):7074-89 PMID: 16356927
- 8. Kim HY et al.. 1995. Translational repressor activity is equivalent and is quantitatively predicted by in vitro RNA binding for two iron-responsive element-binding proteins, IRP1 and IRP2.. J Biol Chem 270(10):4983-6 PMID: 7890603
